Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Henry Schein Acquires Regional Health Care Group, a Medical Distributor Serving the Australia and New Zealand Region
Henry Schein, the world’s largest provider of health care products and services to office-based dental […]
CANbridge Pharmaceuticals Appoints Jason West Vice President, Head of Gene Therapy Research
CANbridge Pharmaceuticals, a global biopharmaceutical company, with a foundation in China, committed to the research, […]
Gameto Expands Executive Team with the Addition of Teri Loxam as Chief Financial Officer
Gameto, a female-led biotech company developing therapies to improve the female reproductive journey, today announced […]
Ossium Health Awarded $3.46M in Funding from the California Institute of Regenerative Medicine
Ossium Health, announced today that the California Institute of Regenerative Medicine (CIRM) has awarded the […]
RenovoRx Appoints Former Chief Medical Officer of Schering-Plough, Robert J. Spiegel, MD, FACP, to Board of Directors
RenovoRx, a biopharmaceutical company focused on targeted drug-delivery with an initial application in locally advanced […]
Antiva Biosciences Closes $53 Million Series E Equity Financing
Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions […]
Therini Bio Raises $36M Series A Financing to Develop Fibrin-Targeted Therapies for Neurodegenerative and Retinal Diseases
Therini Bio, a biotech company aimed at developing fibrin-targeted therapies to treat inflammatory neurodegenerative and […]
Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune
Arix Bioscience, a transatlantic venture capital company focused on investing in breakthrough biotechnology companies, announces […]
Sunovion and Otsuka Initiate Clinical Development of Ulotaront for the Treatment of Generalized Anxiety Disorder
Sunovion Pharmaceuticals and Otsuka Pharmaceutical Development & Commercialization today announced that the first patient has […]
Xencor Appoints Nancy Valente, M.D., as Chief Development Officer
Xencor, a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more